Literature DB >> 14578176

Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele.

Theresa P Pretlow1, Winfried Edelmann, Raju Kucherlapati, Thomas G Pretlow, Leonard H Augenlicht.   

Abstract

The Apc1638N/+ mouse has a chain-terminating mutation in one allele of the adenomatous polyposis coli (Apc) gene that is similar to most mutations observed in the human familial adenomatous polyposis syndrome. Aberrant crypt foci (ACF), the earliest identified neoplastic lesions in the colon, are morphologically abnormal structures that are identifiedmicroscopically in the grossly normal colonic mucosas of rodents treated with colon carcinogens and of human patients. The colons and cecums of 62 Apc1638N/+ mice were evaluated for the spontaneous occurrence of ACF and tumors. Both male and female mice were killed at different times between 5 and 28 weeks of age. Wild-type littermates, ie, Apc(+/+) mice, at 22 to 26 weeks of age served as controls. ACF were identified in 97% of the Apc1638N/+ mice starting at 5 weeks of age and not in any wild-type littermates. Although the number of ACF increased with age (P < 0.0001), the average number of crypts per focus of the ACF did not increase significantly. In addition, wild-type Apc protein was detected by immunohistochemistry in all 22 ACF evaluated. Together these data suggest that heterozygous loss of Apc may be sufficient to initiate ACF in these mice and that these mice may be suitable models to study the interaction of environmental factors with an inherited mutation of the Apc gene that is associated with colon cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578176      PMCID: PMC1892417          DOI: 10.1016/S0002-9440(10)63535-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

2.  Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet.

Authors:  H L Newmark; M Lipkin; N Maheshwari
Journal:  J Natl Cancer Inst       Date:  1990-03-21       Impact factor: 13.506

3.  Adhesion molecules, cellular differentiation, and colonic crypt architecture.

Authors:  L Augenlicht
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

4.  A mouse model of human familial adenomatous polyposis.

Authors:  K Yang; W Edelmann; K Fan; K Lau; V R Kolli; R Fodde; P M Khan; R Kucherlapati; M Lipkin
Journal:  J Exp Zool       Date:  1997-02-15

5.  MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.

Authors:  A H Reitmair; J C Cai; M Bjerknes; M Redston; H Cheng; M T Pind; K Hay; A Mitri; B V Bapat; T W Mak; S Gallinger
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

6.  Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

Authors:  M Oshima; H Oshima; K Kitagawa; M Kobayashi; C Itakura; M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

8.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

Authors:  R Fodde; W Edelmann; K Yang; C van Leeuwen; C Carlson; B Renault; C Breukel; E Alt; M Lipkin; P M Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

Authors:  R F Jacoby; D J Marshall; M A Newton; K Novakovic; K Tutsch; C E Cole; R A Lubet; G J Kelloff; A Verma; A R Moser; W F Dove
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

10.  Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

Authors:  T P Pretlow; B J Barrow; W S Ashton; M A O'Riordan; T G Pretlow; J A Jurcisek; T A Stellato
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  9 in total

1.  Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology.

Authors:  Martin Bortlik; Ivana Vitkova; Martina Papezova; Milada Kohoutova; Ales Novotny; Stanislav Adamec; Petra Chalupna; Milan Lukas
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZxApc1638N mice.

Authors:  Zhenhua Liu; Eric D Ciappio; Jimmy W Crott; Ryan S Brooks; Jared Nesvet; Donald E Smith; Sang-Woon Choi; Joel B Mason
Journal:  FASEB J       Date:  2011-06-06       Impact factor: 5.191

Review 3.  Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.

Authors:  Kenneth W Hance; Hasan E Zeytin; John W Greiner
Journal:  Mutat Res       Date:  2005-08-25       Impact factor: 2.433

4.  A simple device to rapidly prepare whole mounts of murine intestine.

Authors:  R Rudling; A B Hassan; J Kitau; N Mandir; R A Goodlad
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

Review 5.  Mouse models of colorectal cancer.

Authors:  Yunguang Tong; Wancai Yang; H Phillip Koeffler
Journal:  Chin J Cancer       Date:  2011-07

6.  Increased variability in Apc(Min)/+ intestinal tissue can be measured with microultrasound.

Authors:  A Fatehullah; S Sharma; I P Newton; A J Langlands; H Lay; S A Nelson; R K McMahon; N McIlvenny; P L Appleton; S Cochran; I S Näthke
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

7.  Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.

Authors:  Janina Osman; Sayeh Savari; Naveen Kumar Chandrashekar; Kishan Bellamkonda; Desiree Douglas; Anita Sjölander
Journal:  Oncotarget       Date:  2017-05-23

8.  MUC2 mucin deficiency alters inflammatory and metabolic pathways in the mouse intestinal mucosa.

Authors:  Selamawit Tadesse; Georgia Corner; Elena Dhima; Michele Houston; Chandan Guha; Leonard Augenlicht; Anna Velcich
Journal:  Oncotarget       Date:  2017-04-06

9.  Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model.

Authors:  Lieselot Croes; Erik Fransen; Marieke Hylebos; Kimberly Buys; Christophe Hermans; Glenn Broeckx; Marc Peeters; Patrick Pauwels; Ken Op de Beeck; Guy Van Camp
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.